China, U.S. collaborate on AIDS treatment program
Researchers at New York's Aaron Diamond AIDS Research Center have teamed with scientists and health officials in China's Yunan province, home to 35 million people, to develop China's largest HIV/AIDS treatment program, the South China Morning Post reports. The three-year project aims to offer antiretroviral drug therapy to about 300 HIV-positive people in the province. Currently, only about 250 people in the entire nation are taking anti-HIV drugs, according to Yunan health officials. Program participants will be given GlaxoSmithKline's once-a-day anti-HIV drug Trizivir, which contains AZT, 3TC, and Ziagen. The pharmaceutical company will donate the medication for the program.